Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NATIONAL HEALTHCARE CORPNHC · Entity 355 | Director | August 25, 2026 | August 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NATIONAL HEALTHCARE CORP
Report date August 25, 2026 · Filed August 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,030 |
Reported balance
After 2026-08-25 transaction · row 1
1 source rowRow 1 · 2026-08-25 · Sale · Disposed 1,779 · Balance 1,030 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2026 Filed Aug 28, 2026 16:55 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleCommon Stock | 1,779 | $225.42 | $401,022.18 |
DisclosureSEC source: 0001437749-26-029198 · rdgdoc.xml · nonDerivative · entry 1 Gifford David R. · CIK 0002116347 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,030 Read SEC document |
| August 20, 2026 Filed Aug 21, 2026 20:11 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2026 Grant] · Derivative | 6,479 | $0.00 Strike: $171.42 | $0.00 |
DisclosureSEC source: 0001437749-26-028735 · rdgdoc.xml · derivative · entry 3 Gifford David R. · CIK 0002116347 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,479 shares Expires 2031-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 20, 2026 Filed Aug 21, 2026 20:11 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantCommon Stock | 4,691 | $236.75 | $1,110,594.25 |
DisclosureSEC source: 0001437749-26-028735 · rdgdoc.xml · nonDerivative · entry 2 Gifford David R. · CIK 0002116347 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,809 F2 · shares: Shares were withheld by the Company to pay the exercise price. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| August 20, 2026 Filed Aug 21, 2026 20:11 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 6,479 | $171.42 | $1,110,630.18 |
DisclosureSEC source: 0001437749-26-028735 · rdgdoc.xml · nonDerivative · entry 1 Gifford David R. · CIK 0002116347 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 13, 2026 Filed Aug 17, 2026 21:11 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2026 Grant] · Derivative | 1,021 | $0.00 Strike: $171.42 | $0.00 |
DisclosureSEC source: 0001437749-26-028203 · rdgdoc.xml · derivative · entry 2 Gifford David R. · CIK 0002116347 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,479 Underlying: Common Stock · 7,500 shares Expires 2031-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 13, 2026 Filed Aug 17, 2026 21:11 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 1,021 | $171.42 | $175,019.82 |
DisclosureSEC source: 0001437749-26-028203 · rdgdoc.xml · nonDerivative · entry 1 Gifford David R. · CIK 0002116347 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 07, 2026 Filed May 7, 2026 22:06 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2026 Grant] · Derivative | 7,500 | $0.00 Strike: $171.42 | $0.00 |
DisclosureSEC source: 0001437749-26-015695 · rdgdoc.xml · derivative · entry 1 Gifford David R. · CIK 0002116347 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2030-05-06 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.